BioSpace News Archive

Business

Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today reported its financial and operational results for the second quarter ended June 30, 2021.

August 9, 2021
·
6 min read
Business

Myomo Second Quarter 2021 Financial Results Feature Significant Increases in Revenue and Gross Margin, Record Insurance Authorizations and Orders

Myomo, Inc. today announced financial results for the three and six months ended June 30, 2021.

August 9, 2021
·
14 min read
Business

Fulgent Genetics Reports Second Quarter Financial Results

Fulgent Genetics, Inc. today announced financial results for its second quarter ended June 30, 2021.

August 9, 2021
·
18 min read
Business

Cyteir Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights

Cyteir Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2021 and provided an update on recent business highlights.

August 9, 2021
·
9 min read
Business

QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements

QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna™ TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab

August 9, 2021
·
8 min read
Drug Development

Flexion Therapeutics Announces Publication of Results from Phase 2 Pharmacokinetics (PK) and Safety Study of ZILRETTA® in Shoulder Osteoarthritis (OA)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced that the results from the randomized, open-label, Phase 2 pharmacokinetic (PK) trial of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) were published in Drugs in R&D.

August 9, 2021
·
6 min read
Biotech Bay

Sangamo Therapeutics Announces Participation at 2021 Wedbush PacGrow Healthcare Conference

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the 2021 Wedbush PacGrow Healthcare Conference on Wednesday, August 11th at 2:55pm Eastern Time.

August 9, 2021
·
1 min read
Business

Inhibrx Reports Second Quarter 2021 Financial Results

Inhibrx, Inc., a biotechnology company with four clinical programs in development, reported financial results for the second quarter of 2021.

August 9, 2021
·
6 min read
Genetown

Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - Aug 09, 2021

Thermo Fisher Scientific Inc. announced that it has priced an offering of $3.1 billion aggregate principal amount of the following notes

August 9, 2021
·
3 min read
Business

Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results

Organogenesis Holdings Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, reported financial results for the three and six months ended June 30, 2021.

August 9, 2021
·
19 min read